• C.W. Kee, O. Tack, F. Guibbal, T.C. Wilson, P.G. Isenegger, M. Imiołek, S. Verhoog, M. Tilby, G. Boscutti, S. Ashworth, J. Chupin, R. Kashani, A.W.J. Poh, J.K. Sosabowski, S. Macholl, C. Plisson, B. Cornelissen, M.C. Willis, J. Passchier, B.G. Davis, and V. Gouverneur, "18F-Trifluoromethanesulfinate Enables Direct C–H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides", Journal of the American Chemical Society, vol. 142, pp. 1180-1185, 2020. http://dx.doi.org/10.1021/jacs.9b11709
  • Chemically modified new modalities (Astra-Zeneca)

  • W. Yang, P. Gadgil, V.R. Krishnamurthy, M. Landis, P. Mallick, D. Patel, P.J. Patel, D.L. Reid, and M. Sanchez-Felix, "The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules", The AAPS Journal, vol. 22, 2020. http://dx.doi.org/10.1208/s12248-019-0402-2
  • [1]
    highlighted in https://www.chemistryworld.com/news/synthetic-strategy-exploits-fluxional-nitrogen-to-deliver-three-chiral-centres-for-the-price-of-one/4011029.article

  • C. Dean, S. Rajkumar, S. Roesner, N. Carson, G.J. Clarkson, M. Wills, M. Jones, and M. Shipman, "Readily accessible sp3-rich cyclic hydrazine frameworks exploiting nitrogen fluxionality", Chemical Science, vol. 11, pp. 1636-1642, 2020. http://dx.doi.org/10.1039/C9SC04849A